Did the pulmonogist or cardiologist ever mention "patent Foramen Ovale" PFO? Laymen terms it is a hole in the heart that is present in fetus but sometimes does not close in some people. Can produce no symtoms in life but does give more risk of certain vasular injuries such as stroke and pulmonary embolism.
Why I ask is a high altitude study showed a link between climbers susceptible to HA pulmonary edema and PFO.
Study
The key features of HAPE are exaggerated pulmonary hypertension and arterial hypoxemia at high altitude. The mechanisms underlying the condition are not fully understood, but there is evidence that a PFO may worsen the hypoxemia seen.
In the current study, Dr. Yves Allemann, from the Swiss Cardiovascular Center in Bern, and colleagues used transesophageal echocardiography to look for PFOs in 16 HAPE-susceptible mountaineers and in 19 mountaineers resistant to HAPE. Pulmonary artery pressure was estimated with Doppler echocardiography and pulse oximetry was used to determine oxygen saturation. All measurements were taken at high and low altitudes.
At low altitude, the PFO rates were 56% and 11% in HAPE-sensitive and -resistant subjects, respectively (p = 0.004). Similarly, at high altitude, the corresponding rates were 69% and 16%.
Prior to the onset of pulmonary edema at high altitude, HAPE-susceptible subjects had an oxygen saturation of 73%, significantly lower than the 83% noted in controls (p = 0.001). In HAPE-susceptible subjects, a large PFO was associated with a mean oxygen saturation of 65%, whereas with smaller or no PFO the saturation was 77%.
"We speculate that at high altitude, a large PFO may contribute to exaggerated arterial hypoxemia and facilitate HAPE," the investigators conclude.
The key features of HAPE are exaggerated pulmonary hypertension and arterial hypoxemia at high altitude. The mechanisms underlying the condition are not fully understood, but there is evidence that a PFO may worsen the hypoxemia seen.
In the current study, Dr. Yves Allemann, from the Swiss Cardiovascular Center in Bern, and colleagues used transesophageal echocardiography to look for PFOs in 16 HAPE-susceptible mountaineers and in 19 mountaineers resistant to HAPE. Pulmonary artery pressure was estimated with Doppler echocardiography and pulse oximetry was used to determine oxygen saturation. All measurements were taken at high and low altitudes.
At low altitude, the PFO rates were 56% and 11% in HAPE-sensitive and -resistant subjects, respectively (p = 0.004). Similarly, at high altitude, the corresponding rates were 69% and 16%.
Prior to the onset of pulmonary edema at high altitude, HAPE-susceptible subjects had an oxygen saturation of 73%, significantly lower than the 83% noted in controls (p = 0.001). In HAPE-susceptible subjects, a large PFO was associated with a mean oxygen saturation of 65%, whereas with smaller or no PFO the saturation was 77%.
"We speculate that at high altitude, a large PFO may contribute to exaggerated arterial hypoxemia and facilitate HAPE," the investigators conclude.